From: PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing
Features | TRGAted | UALCAN | Path2Surv | METABRIC-pathway-survival | GNOSIS | CASAS | Esurv | Kmplot | Survival Genie | PATH-SURVEYOR |
---|---|---|---|---|---|---|---|---|---|---|
Pathway-level Survival Analysis | No | No | Yes | Yes | No | No | Yes | No | Yes | Yes |
Network Connectivity Analysis | No | No | No | No | No | No | No | No | No | Yes |
Hazard ratio-ranked GSEA Pathway Analysis | No | No | No | No | No | No | No | No | No | Yes |
Immune-deconvolution Survival Analysis | No | No | No | No | No | No | No | No | Yes | Yes |
Gene-level Survival Analysis | No | Yes | No | No | Yes | No | Yes | Yes | Yes | Yes |
Univariate Survival Analysis of Other Patient/Sample Features | No | No | Yes | Yes | Yes | Yes | No | No | Yes | Yes |
Multivariate Survival Analysis | No | Yes | No | Yes | Yes | No | No | Yes | No | Yes |
Examining Covariate Distributions and associations (QC) | No | Yes | No | No | Yes | No | No | No | No | Yes |
Plug-and-Play User Inputs | No | No | No | No | No | Yes | Yes | Yes | No | Yes |